Position in MRK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,958,185
+$517,290 QoQ
Shares Held
30,803
+7.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#1,155
of 3,769 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARVEST INVESTMENTS, INC. holds $10,070,233 across 7 Drug Manufacturers - General names. MRK ranks #1 (39.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
30,803 | $3,958,185 | |
| 2 | JNJ |
Johnson & Johnson
|
7,022 | $1,783,377 | |
| 3 | ABBV |
AbbVie Inc.
|
6,201 | $1,560,419 | |
| 4 | LLY |
ELI LILLY & Co
|
918 | $1,101,076 | |
| 5 | PFE |
Pfizer Inc
|
31,383 | $755,702 | |
| 6 | NVS |
Novartis AG
|
3,314 | $519,370 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,805 | $392,104 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,958,185 | 30,803 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $3,440,895 | 28,605 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,290,427 | 31,260 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,767,172 | 32,970 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $3,166,637 | 40,003 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $4,067,564 | 45,316 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,835,053 | 38,551 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,376,602 | 38,540 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,602,017 | 37,173 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,954,854 | 37,551 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $4,721,438 | 43,308 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||